A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells

BACKGROUND: Chronic limb-threatening ischemia (CLTI) represents the final stage of peripheral arterial disease. Approximately one-third of patients with CLTI are not eligible for conventional surgical treatments. Furthermore, patients with advanced stage of CLTI are prone to amputation and death. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Arango-Rodríguez, Martha L., Mateus, Ligia C., Sossa, Claudia L., Becerra-Bayona, Silvia M., Solarte-David, Víctor Alfonso, Ochoa Vera, Miguel Enrique, Viviescas, Lady T. Giratá, Berrio, Ana M. Vera, Serrano, Sergio Eduardo, Vargas, Oliverio, Isla, Andrés Catalá, Benitez, Alape, Rangel, Germán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464344/
https://www.ncbi.nlm.nih.gov/pubmed/37626416
http://dx.doi.org/10.1186/s13287-023-03427-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464344/
https://www.ncbi.nlm.nih.gov/pubmed/37626416
http://dx.doi.org/10.1186/s13287-023-03427-z

Ejemplares similares